Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
34.08
+0.06 (0.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Legend Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 |
| Market Capitalization | 6,252 | 10,938 | 8,357 | 7,175 | 3,735 | - | |
| Market Cap Growth | -26.66% | 30.89% | 16.46% | 92.11% | - | - | |
| Enterprise Value | 5,386 | 9,835 | 7,695 | 6,613 | 3,163 | - | |
| Last Close Price | 34.08 | 60.17 | 49.92 | 46.61 | 28.16 | - | |
| PS Ratio | 11.95 | 38.36 | 71.42 | 104.25 | 49.80 | - | |
| PB Ratio | 5.60 | 8.74 | 11.23 | 9.37 | 6.25 | - | |
| P/TBV Ratio | 8.06 | 8.77 | 11.28 | 9.43 | 6.28 | - | |
| EV/Sales Ratio | 10.35 | 34.49 | 65.76 | 96.08 | 42.17 | - | |
| Debt / Equity Ratio | 0.31 | 0.26 | 0.38 | 0.16 | 0.01 | 0.04 | |
| Asset Turnover | 0.29 | 0.18 | 0.10 | 0.07 | 0.15 | 0.17 | |
| Inventory Turnover | 29.25 | 35.35 | 66.27 | 176.58 | 157.02 | - | |
| Quick Ratio | 4.86 | 6.77 | 3.59 | 4.11 | 5.09 | 2.00 | |
| Current Ratio | 4.98 | 6.92 | 3.69 | 4.14 | 5.14 | 2.25 | |
| Return on Equity (ROE) | -28.35% | -51.94% | -59.11% | -59.19% | -71.12% | -127.01% | |
| Return on Assets (ROA) | -12.28% | -17.39% | -23.37% | -26.75% | -28.32% | -22.95% | |
| Return on Capital (ROIC) | -14.06% | -21.19% | -29.86% | -33.05% | -37.86% | -97.08% | |
| Earnings Yield | -5.57% | -4.74% | -5.34% | -5.62% | -7.13% | - | |
| FCF Yield | -2.78% | -3.78% | -2.66% | -3.35% | -6.67% | - | |
| Buyback Yield / Dilution | -6.16% | -10.71% | -12.91% | -19.21% | -18.15% | - | |
| Total Shareholder Return | -6.16% | -10.71% | -12.91% | -19.21% | -18.15% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.